Totaligent Enters APAC Medical Tourism Market at Historic Inflection Point, as Global Healthcare Travel Surges Toward $274 Billion

Totaligent, Inc. (OTCID: TGNT) announced its strategic entry into the Asia-Pacific medical tourism market through its Aetherium Medical platform acquisition. The company is positioning itself to connect biotech companies with APAC's rapidly growing medical tourism infrastructure, which is projected to reach $273.7 billion by 2032. The platform will launch with Japan as its cornerstone, leveraging Japan's progressive regenerative medicine regulatory framework. Totaligent expects to close a joint venture with GloMed Solutions within two weeks, providing immediate access to over 20 specialty clinics across APAC.